Literature DB >> 12854830

Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.

Dongxu Sun1, Aparna Krishnan, Khaliquz Zaman, Richard Lawrence, Arunabh Bhattacharya, Gabriel Fernandes.   

Abstract

UNLABELLED: The mechanisms of action of dietary fish oil (FO) on osteoporosis are not fully understood. This study showed FO decreased bone loss in ovariectomized mice because of inhibition of osteoclastogenesis. This finding supports a beneficial effect of FO on the attenuation of osteoporosis.
INTRODUCTION: Consumption of fish or n-3 fatty acids protects against cardiovascular and autoimmune disorders. Beneficial effects on bone mineral density have also been reported in rats and humans, but the precise mechanisms involved have not been described.
METHODS: Sham and ovariectomized (OVX) mice were fed diets containing either 5% corn oil (CO) or 5% fish oil (FO). Bone mineral density was analyzed by DXA. The serum lipid profile was analyzed by gas chromatography. Receptor activator of NF-kappaB ligand (RANKL) expression and cytokine production in activated T-cells were analyzed by flow cytometry and ELISA, respectively. Osteoclasts were generated by culturing bone marrow (BM) cells with 1,25(OH)2D3. NF-kappaB activation in BM macrophages was measured by an electrophoretic mobility shift assay. RESULTS AND
CONCLUSION: Plasma lipid C16:1n6, C20:5n3, and C22:6n3 were significantly increased and C20:4n6 and C18:2n6 decreased in FO-fed mice. Significantly increased bone mineral density loss (20% in distal left femur and 22.6% in lumbar vertebrae) was observed in OVX mice fed CO, whereas FO-fed mice showed only 10% and no change, respectively. Bone mineral density loss was correlated with increased RANKL expression in activated CD4+ T-cells from CO-fed OVX mice, but there was no change in FO-fed mice. Selected n-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) added in vitro caused a significant decrease in TRACP activity and TRACP+ multinuclear cell formation from BM cells compared with selected n-6 fatty acids (linoleic acid [LA] and arachidonic acid [AA]). DHA and EPA also inhibited BM macrophage NF-kappaB activation induced by RANKL in vitro. TNF-alpha, interleukin (IL)-2, and interferon (IFN)-gamma concentrations from both sham and OVX FO-fed mice were decreased in the culture medium of splenocytes, and interleukin-6 was decreased in sham-operated FO-fed mice. In conclusion, inhibition of osteoclast generation and activation may be one of the mechanisms by which dietary n-3 fatty acids reduce bone loss in OVX mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854830     DOI: 10.1359/jbmr.2003.18.7.1206

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  76 in total

1.  Omega-3 fatty acid effect on alveolar bone loss in rats.

Authors:  L Kesavalu; B Vasudevan; B Raghu; E Browning; D Dawson; J M Novak; M C Correll; M J Steffen; A Bhattacharya; G Fernandes; J L Ebersole
Journal:  J Dent Res       Date:  2006-07       Impact factor: 6.116

2.  Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women.

Authors:  Lee-Jane W Lu; Fatima Nayeem; Karl E Anderson; James J Grady; Manubai Nagamani
Journal:  J Nutr       Date:  2008-12-23       Impact factor: 4.798

Review 3.  Metabolic reprogramming in osteoclasts.

Authors:  Kyung-Hyun Park-Min
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

4.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.

Authors:  Catherine M Donlon; Meryl S LeBoff; Sharon H Chou; Nancy R Cook; Trisha Copeland; Julie E Buring; Vadim Bubes; Gregory Kotler; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-02-23       Impact factor: 2.226

5.  Higher sea fish intake is associated with greater bone mass and lower osteoporosis risk in postmenopausal Chinese women.

Authors:  Y-m Chen; S C Ho; S S Lam
Journal:  Osteoporos Int       Date:  2009-08-06       Impact factor: 4.507

6.  An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption.

Authors:  B S Herrera; T Ohira; L Gao; K Omori; R Yang; M Zhu; M N Muscara; C N Serhan; T E Van Dyke; R Gyurko
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

7.  Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.

Authors:  A M Tyagi; K Srivastava; J Kureel; A Kumar; A Raghuvanshi; D Yadav; R Maurya; A Goel; D Singh
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

8.  Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice.

Authors:  Arunabh Bhattacharya; M Mizanur Rahman; Roger McCarter; Marianne O'Shea; Gabriel Fernandes
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

9.  The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet.

Authors:  Mizanur Rahman; Ganesh V Halade; Arunabh Bhattacharya; Gabriel Fernandes
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  Suppression of nuclear factor-kappaB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles.

Authors:  Clara De Pascale; Valerie Graham; Robert C Fowkes; Caroline P D Wheeler-Jones; Kathleen M Botham
Journal:  FEBS J       Date:  2009-09-02       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.